drugset / Trial / NCT05572060

Effect of Metformin Use on Mortality in Diabetic and Non Diabetic Patients With Sepsis and Septic Shock.

NCT05572060 ↗

Unknown 75 enrolled Assiut University
RandomizedParallel-groupDouble-blindTreatment

Summary

We aimed to determine if metformin use in both diabetic and non diabetic patients with sepsis and septic shock affects 28 day mortality and its effect on inflammatory markers. Plasma rennin, serum lactate concentration and IL6 will be measured for predicting 28 days in-hospital mortality in patients with sepsis.

Timeline

Start
2022-12-01
Primary completion
2024-12-31
Completion
2025-01-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 500 mg Oral